NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Owner Susan Baroff, who inherited the business from her father, said it just feels like the right time to close the business now. WBZ-TV’s Samantha Chaney reports.Read More